131 related articles for article (PubMed ID: 16259564)
21. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers.
Park MR; Han KO; Han IK; Cho MH; Nah JW; Choi YJ; Cho CS
J Control Release; 2005 Jul; 105(3):367-80. PubMed ID: 15936108
[TBL] [Abstract][Full Text] [Related]
22. Chimeric RNA/ethylene-bridged nucleic acids promote dystrophin expression in myocytes of duchenne muscular dystrophy by inducing skipping of the nonsense mutation-encoding exon.
Surono A; Van Khanh T; Takeshima Y; Wada H; Yagi M; Takagi M; Koizumi M; Matsuo M
Hum Gene Ther; 2004 Aug; 15(8):749-57. PubMed ID: 15319032
[TBL] [Abstract][Full Text] [Related]
23. Modular synthesis of folate conjugated ternary copolymers: polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate for targeted gene delivery.
Liu L; Zheng M; Renette T; Kissel T
Bioconjug Chem; 2012 Jun; 23(6):1211-20. PubMed ID: 22548308
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells.
Aartsma-Rus A; Kaman WE; Bremmer-Bout M; Janson AA; den Dunnen JT; van Ommen GJ; van Deutekom JC
Gene Ther; 2004 Sep; 11(18):1391-8. PubMed ID: 15229633
[TBL] [Abstract][Full Text] [Related]
25. Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo.
Wang M; Wu B; Tucker JD; Shah SN; Lu P; Lu Q
J Nanobiotechnology; 2020 Feb; 18(1):34. PubMed ID: 32070342
[TBL] [Abstract][Full Text] [Related]
26. Optimizing RNA/ENA chimeric antisense oligonucleotides using in vitro splicing.
Takeshima Y; Yagi M; Matsuo M
Methods Mol Biol; 2012; 867():131-41. PubMed ID: 22454059
[TBL] [Abstract][Full Text] [Related]
27. PEGylated poly(ethylene imine) copolymer-delivered siRNA inhibits HIV replication in vitro.
Weber ND; Merkel OM; Kissel T; Muñoz-Fernández MÁ
J Control Release; 2012 Jan; 157(1):55-63. PubMed ID: 21930169
[TBL] [Abstract][Full Text] [Related]
28. Physicochemical and biological characterization of polyethylenimine-graft-poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes.
Brus C; Petersen H; Aigner A; Czubayko F; Kissel T
Bioconjug Chem; 2004; 15(4):677-84. PubMed ID: 15264853
[TBL] [Abstract][Full Text] [Related]
29. Poly(ethylene oxide) grafted with short polyethylenimine gives DNA polyplexes with superior colloidal stability, low cytotoxicity, and potent in vitro gene transfection under serum conditions.
Zheng M; Zhong Z; Zhou L; Meng F; Peng R; Zhong Z
Biomacromolecules; 2012 Mar; 13(3):881-8. PubMed ID: 22339316
[TBL] [Abstract][Full Text] [Related]
30. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles.
Lu QL; Rabinowitz A; Chen YC; Yokota T; Yin H; Alter J; Jadoon A; Bou-Gharios G; Partridge T
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):198-203. PubMed ID: 15608067
[TBL] [Abstract][Full Text] [Related]
31. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
[TBL] [Abstract][Full Text] [Related]
32. Self-aggregating 1.8kDa polyethylenimines with dissolution switch at endosomal acidic pH are delivery carriers for plasmid DNA, mRNA, siRNA and exon-skipping oligonucleotides.
Chiper M; Tounsi N; Kole R; Kichler A; Zuber G
J Control Release; 2017 Jan; 246():60-70. PubMed ID: 27956144
[TBL] [Abstract][Full Text] [Related]
33. Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.
Heemskerk H; de Winter CL; van Ommen GJ; van Deutekom JC; Aartsma-Rus A
Ann N Y Acad Sci; 2009 Sep; 1175():71-9. PubMed ID: 19796079
[TBL] [Abstract][Full Text] [Related]
34. Pluronic-PEI copolymers enhance exon-skipping of 2'-O-methyl phosphorothioate oligonucleotide in cell culture and dystrophic mdx mice.
Wang M; Wu B; Lu P; Tucker JD; Milazi S; Shah SN; Lu QL
Gene Ther; 2014 Jan; 21(1):52-9. PubMed ID: 24131982
[TBL] [Abstract][Full Text] [Related]
35. By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping.
Mitrpant C; Fletcher S; Iversen PL; Wilton SD
J Gene Med; 2009 Jan; 11(1):46-56. PubMed ID: 19006096
[TBL] [Abstract][Full Text] [Related]
36. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
Errington SJ; Mann CJ; Fletcher S; Wilton SD
J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
[TBL] [Abstract][Full Text] [Related]
37. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.
Ikezawa M; Cao B; Qu Z; Peng H; Xiao X; Pruchnic R; Kimura S; Miike T; Huard J
Hum Gene Ther; 2003 Nov; 14(16):1535-46. PubMed ID: 14577915
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
39. Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo.
Neu M; Germershaus O; Behe M; Kissel T
J Control Release; 2007 Dec; 124(1-2):69-80. PubMed ID: 17897749
[TBL] [Abstract][Full Text] [Related]
40. Polyelectrolyte complex micelles composed of c-raf antisense oligodeoxynucleotide-poly(ethylene glycol) conjugate and poly(ethylenimine): effect of systemic administration on tumor growth.
Jeong JH; Kim SH; Kim SW; Park TG
Bioconjug Chem; 2005; 16(4):1034-7. PubMed ID: 16029047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
